The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ARROWHEAD PHARMACEUTICALS IN | COM | 04280A100 | 5,836,584 | 143,900 | SH | SOLE | 143,900 | 0 | 0 | |||
ATARA BIOTHERAPEUTICS INC | COM | 046513107 | 1,440,904 | 439,300 | SH | SOLE | 439,300 | 0 | 0 | |||
BRIDGEBIO PHARMA INC | COM | 10806X102 | 3,192,780 | 419,000 | SH | SOLE | 419,000 | 0 | 0 | |||
CURIS INC | COM NEW | 231269200 | 2,465,178 | 4,482,142 | SH | SOLE | 4,482,142 | 0 | 0 | |||
INVIVYD INC | COM | 00534A102 | 13,872,375 | 9,248,250 | SH | SOLE | 9,248,250 | 0 | 0 | |||
IONIS PHARMACEUTICALS INC | COM | 462222100 | 4,770,351 | 126,300 | SH | SOLE | 126,300 | 0 | 0 | |||
NEXIMMUNE INC | COM | 65344D109 | 32,440 | 133,442 | SH | SOLE | 133,442 | 0 | 0 | |||
PROQR THRAPEUTICS N V | SHS EURO | N71542109 | 7,069,220 | 1,910,600 | SH | SOLE | 1,910,600 | 0 | 0 | |||
ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 14,131,106 | 722,080 | SH | SOLE | 722,080 | 0 | 0 | |||
SILENCE THERAPEUTICS PLC | ADS | 82686Q101 | 2,224,975 | 145,900 | SH | SOLE | 145,900 | 0 | 0 | |||
SPRINGWORKS THERAPEUTICS INC | COM | 85205L107 | 2,858,499 | 109,900 | SH | SOLE | 109,900 | 0 | 0 | |||
STOKE THERAPEUTICS INC | COM | 86150R107 | 4,457,075 | 482,890 | SH | SOLE | 482,890 | 0 | 0 | |||
TG THERAPEUTICS INC | COM | 88322Q108 | 1,235,052 | 104,400 | SH | SOLE | 104,400 | 0 | 0 | |||
WAVE LIFE SCIENCES LTD | SHS | Y95308105 | 41,323,835 | 5,903,405 | SH | SOLE | 5,903,405 | 0 | 0 |